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Inherited complement component deficiencies in membranoprolifera.
tive glomerulonephritis. Anecdotal reports of complement component
deficiencies in patients with immune complex disease led to a systemat-
ic study of the levels of seven complement components in serum
specimens from 178 patients with glomerulonephritis and 163 normal
subjects. Deficiencies were found with significantly higher frequency
(22.7%) among 44 patients with membranoproliferative glomerulone-
phritis (MPGN) types I and III, than among the normal subjects (6.7%,P < 0.002) or among 134 patients with other glomerulonephritides
(5.2%, P < 0.001). The component deficiencies in MPGN were partial
in nine patients and subtotal in one. They could not be ascribed to
acquired hypocomplementemia or to a nephrotic syndrome. They were
present over long periods, were found in family members, and involved
C2, C3, factor B, C6, C7, and C8. Six were presumably the result of null
structural genes, two were associated with a structurally abnormal
component, and two were of unknown cause. The results give evidence
that partial deficiency of one or more complement components is a
factor predisposing to MPGN.
Deficits héréditaires en facteurs du complement au cours de Ia glomeru-
lonéphrite membrano-proliférative. Des publications occasionnelles de
deficits en facteurs du complement chez des malades avec des maladies
a immuns complexes a conduit a une étude systématique des taux de
sept facteurs du complement dans les échantillons seriques de 178
malades atteints de glomCrulonéphrite et de 163 sujets normaux. Des
deficits ont etC trouvCs avec une frCquence significativement plus
ClevCe (22,7%) parmi 44 malades atteints de glomCrulonCphrite mem-
brano-prolifCrative (MPGN) de types I et III que parmi des sujets
normaux (6,7%, P < 0,002) ou 134 malades atteints d'autres gloméru-
lonCphntes (5,2%, P < 0,001). Les deficits au cours des MPGN étaient
partiels dans neuf cas, et subtotaux dans un. Ils ne pouvaient être
attribués a une hypercomplémentemie acquise ou a un syndrome
nCphrotique. Ils Ctaient presents pendant de longues pdriodes, étaient
trouvés chez certains membres des familles, et touchaient le C2, le C3,
le facteur B, le C6, le C7, et le C8. Six étaient probablement le résultat
de l'absence de genes de structures, deux étaient associés a un facteur
de structure anormale, et deux étaient de cause inconnue. Ces résultats
apportent Ia preuve qu'un deficit partiel d'un ou plusieurs facteurs du
complement constitue un facteur prCdisposant a Ia MPGN.
Anecdotal observations in the past decade have suggested an
association of defects of the serum complement system with
immune complex disease. For example, an association has been
noted between deficiencies of the subcomponents of Cl and
glomerulonephritis, skin rash, and arthritis [1—4], as well as
between homozygous deficiencies of C2 [5, 6], C4 [7, 8] or the
terminal complement components [9] and systemic lupus ery-
thematosus (SLE) or SLE-like illnesses. Five patients with
membranoproliferative glomerulonephritis (MPGN) have been
reported to have very low levels of, or undetectable, C2. Four
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were presumably homozygous deficient [10—131 and a fifth had
hereditary angioneurotic edema [14].
Immune complex disease has also been noted in patients with
partial component deficiencies. Glass et al [15] found heterozy-
gous C2 deficiency to be unusually frequent among patients
with SLE. Immune complex disease has also accompanied low
serum C3 levels associated with heterozygous C3 deficiency
[16], a hypomorphic variant of C3 [17], and low serum factor H
levels [18].
There has been no previous attempt to determine in a
systematic manner for a large number of complement compo-
nents the prevalence of component deficiencies in patients with
immune complex disease. To this end, seven components of the
complement system were measured on 178 patients with gb-
merulonephritis, 163 normal subjects and, where appropriate,
their families. The acquired hypocomplementemia which char-
acterizes many forms of glomerulonephritis was eliminated as a
cause of partial component deficiency by, with few exceptions,
confining the study to serum specimens in which the C3
concentration was within the normal range and by showing that
the same deficiency was present in healthy family members.
Inherited deficiencies of components were found in ten of 44
patients with MPGN types I and III, a frequency significantly
greater than that found in MPGN type II, in normal subjects or
in patients with other forms of glomerulonephritis.
Methods
Patients. Of the 178 patients with glomerulonephritis on
whom complement profiles were obtained, 58 had MPGN, 62
acute postinfectious glomerulonephritis (AGN), 26 Henoch-
SchOnlein nephritis, and 32 SLE. Of the 58 with MPGN, 24 had
type I, 14, type II, and 20, type III. Complement components
were also measured on specimens from 163 normal hospital
personnel. All patients with MPGN were Caucasian, as were all
but one of the normal subjects and the majority of patients with
other nephritides.
The type of MPGN was usually determined by electron
microscopy [191 of renal biopsy tissue. Material adequate for
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determining type by this means was available in 21 of 24 with
type I (subendothelial deposits), 11 of 14 with type II (dense
deposit disease), and 18 of 20 with type III (mixed subendothe-
hal and subepithelial deposits with disruption of the basement
membrane). When material for electron microscopy was not
available, the diagnosis was made by typical changes by light
and fluorescence microscopy [19].
AGN and Henoch-SchOnlein nephritis were usually diag-
nosed clinically [20]; in 20 of 62 with AGN and 11 of 26 with
Henoch-Schönlein nephritis, the diagnosis was made by renal
biopsy. A renal biopsy was performed on 27 of the 32 patients
with SLE.
Measurement of complement proteins. Complement protein
levels were measured either on fresh serum specimens from
blood allowed to clot at room temperature or on specimens
stored at —70°C. The complement profile consisted of the
measurement immunochemically by radial immunodiffusion of
C2, C3, C5, C6, C7, C8, and factor B. The source and
characteristics of the antisera for the immunochemical mea-
surement of C3, CS, and factor B were described previously
[2 1—22]. Antisera to C2, C6, C7, and C8 were raised in goats. C2
and C8 antigen were purchased from Cordis Laboratories,
Miami, Florida, and C6 antigen was a gift of Dr. Carlos
Arroyave, University of Colorado Medical Center, Denver,
Colorado. For C7, washed agarose containing the precipitate
from the reaction of normal human serum with monospecific
antiserum, a gift of Dr. Robert Schreiber, Scripps Clinic and
Research Foundation, La Jolla, California, was injected. These
antisera were made monospecific by absorption with normal
human serum (NHS) heated to 56°C for 60 mm (anti-C2 and
anti-C6), with NHS depleted of a single complement component
by immunoabsorption (anti-C6 and anti-C7), with a precipitate
of NHS made with 5% polyethylene glycol (anti-C7), and with a
serum in which C8 was in low concentration as the result of
heterozygous deficiency (anti-C8).
The measurements of C2, C6, C7, and C8 were standardized
by means of a reference serum in which these proteins had been
quantitated by the Department of Molecular Immunology at
Scripps Clinic and Research Foundation. Measurements were
made in duplicate and included on each RID plate was a
complete set of standards consisting of dilutions of the refer-
ence serum.
The means and SD of the serum levels in mg/dl of the
complement proteins measured for this study in the 163 normal
hospital personnel were as follows: C2, 2.74 0.42; C3, 127.4
20.7; CS, 5.66 0.96; C6, 5.44 0.74; C7, 5.68 1.09; C8,
4.40 0.71; and factor B, 22.4 4.5. To simplify presentation
of the data, serum concentrations of the components are
expressed in SD below the mean, calculated as concentration —
mean/SD. Assuming a normal distribution curve, 2.15% of
normal values fall between 2 and 3 SD below the mean and
0.13% are more than 3 SD below the mean.
Criteria for diagnosis of inherited complement component
deficiency. With the exception of five patients, only comple-
ment profiles in which the C3 level was in the normal range
were used for screening component deficiencies. Normalization
of C3 occurred either in the natural course of the hypocomple-
mentemic nephritis or as a result of treatment. The five excep-
tions were one patient with MPGN III (patient 7) whose low C3
level was familial and four who had persistent acquired hypo-
Fig. 1. Serum C2 and C3 concentrations, expressed as SD from the
mean, plotted versus age for MPGN patients I to 3 with probable
heterozygous C2 deficiency. The shaded areas indicate the normal
range (mean 2 SD).
and will be described below and three had SLE. None of those
with SLE had inherited deficiencies as judged by family studies.
An obvious requirement for heterozygous deficiency of struc-
tural genes for C6, C7, and C8 is that the patient be phenotypi-
cathy homozygous for a variant of the protein. To aid in
identifying heterozygosity, the structural variants of these
proteins were determined by isoelectric focusing in polyacryl-
amide or agarose [23]. For isoelectric focusing in polyacryl-
amide, determination of the phenotype was by hemolytic over-
lay [24] and, in agarose, by immunofixation using monospecific
antisera made as described above. In the case of C6, both
hemolytic overlay and immunofixation were used and the two
methods gave identical results. In the case of C7, only immuno-
fixation was used. The alpha-gamma chain of the C8 of patient
10 and her family were typed by hemolytic overlay in the
laboratory of Dr. Chester A. Alper [25]. In our laboratory, C8
has also been typed on this patient and others by immunofixa-
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Fig. 2. Serum C6 and C3 concentrations, expressed as SD from the
mean, plotted versus age for MPGN patients 4 and 5 with probable
heterozygous C6 deficiency. The plot is the same as that for Figure 1
tion after isoelectric focusing in agarose under nondissociating
conditions. In conformity with the C6 nomenclature [24], C8
producing bands focusing toward the anode was designated
C8A and that with predominant bands more cathodal, C8B.
Results
Prevalence of inherited complement component deficiency in
patients with MPGN types I and III. Of the 44 patients with
MPGN types I and III, nine were found to be partially deficient
in one or more serum complement components and one subto-
tally deficient in two components. The serum levels of the
deficient components, and the concurrently measured levels of
C3, are plotted against age for the nine patients with partial
deficiencies in Figures 1 to 4. Data are not graphed for the
patient who had subtotal deficiency of C6 and C7 since mean-
ingful serial measurements by RID were not possible. Serum
levels of all measured complement components in these pa-
tients are given in Table 1.
Three of the 44 patients were probably heterozygous C2
deficient. As shown in Figure 1, serum concentrations of C2,
measured serially over periods of 4 to 6 years were, on all but
one occasion, more than 2 SD below the mean and levels more
than 3 SD below the mean were not uncommon. At the time of
all measurements, levels of C3 as well as of the other comple-
ment components were within the normal range or even elevat-
ed (Fig. 1, Table 1). Serum levels of C2 in family members of
these patients, expressed as SD below the mean, are shown
graphically in Figure 5. In every case, at least one family
member was deficient. In the family of patient 1, HLA haplo-
Fig. 3. Concentration of serum complement components found to be
deficient in MPGN patients 7 to 9. The concentrations of C3 are also
shown. The plot is the same as that for Figure 1. The period during
which patient 9 was pregnant is indicated by the vertical lines.
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Fig. 4. Serum C3, C6, C7, and C8 concentrations in patient 10 with C8
deficiency expressed as SD from the mean. The plot is the same as that
for Figure 1.
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Table 1. Serum concentrations of complement components in ten patients with MPGN with component deficiencies
Patient no.
Age at
diagnosis
years
C2 C3 CS C6 C7 C8 Factor B
mg/dl
1 17 1.2 142 5.5 5.4 5.8 3.3 27.9
2 8 1.3 111 4.9 5.0 5.1 5.0 17.7
3 6 1.3 122 5.6 6.0 5.4 4.0 22.8
4 5 2.4 144 4.6 3.2 6.1 4.2 22.8
5 9 4.1 131 6.2 2.9 4.4 3.1 21.5
6 7 2.5 127 5.2 0 0 3.9 17.9
7 9 2.8 58 3.1 4.2 3.8 3.6 14.4
8 15 2.9 116 4.5 5.6 2.2 3.8 15.4
9 8 2,5 138 5.5 3.4 3.6 3.1 20.2
10 13 2.8 60 4.5 4.8 5.2 2.6 19.8
Normalrange 1.9to3.6 86to 169 3.8to7.6 4.Oto6.9 3.5to7.9 3.OtoS.8 13.3to31.5
Abnormally low values are italicized.
type AlO Bl8 was present in the propositus and deficient family
members. In patient 2, the haplotype associated with C2
deficiency was A9 B40141 and in patient 3, A2 Bl2. DR typing
was not performed.
Patient 4, over a 4-year period when levels of C3 and other
components were in the normal range, consistently had low
levels of C6 (Fig. 2, Table 1). A low C6 concentration was also
found in her sister (Fig. 5). The family pedigree is shown in
Figure 6. Although the level of C6 in her mother was normal and
blood from the father was not available, it is probable that a null
gene for C6 is present. The C6 phenotype of both the propositus
and her sister was A and that of the mother, AB. The relative
likelihood that the father is heterozygous deficient versus that
he is AA or AB is 82%. This value was calculated from the
known frequency of C6 alleles in the general population [241 and
from the distribution of serum levels for both the heterozygous
deficient and the "normal" genotype in the population, as
determined in the present study, using Baye's theorem of
conditioned probabilities [261.
Low levels of C6 were also consistently found in patient 5
while the levels of C3 and other components were normal (Fig.
2 and Table 1). She may also have a genetic deficiency of C7 in
that the concentrations of both C6 and C7 in the serum of her
mother and maternal grandfather were low (Figs. 5 and 6). The
C7 level of the propositus was, however, not depressed (Table
1). Genetic deficiencies of these two proteins segregate, indicat-
ing their loci are closely linked [27] and dual C6-C7 deficiency
has been reported previously [28, 29]. Phenotypically, the
maternal grandfather was C6A while the maternal grandmother
and the mother were C6B (Fig. 6). Thus, the mother did not
inherit the C6 variant present in her partially deficient father,
informative for the presence of a null structural gene [291. The
patient's father was C6AB. All were phenotypically C7' [30].
Patient 6 was similar to a healthy man with subtotal combined
C6-C7 deficiency reported by Lachmann, Hobart, and Woo
[28]; both components were present in very low concentration.
From eluates of columns of immobilized anti-C6 and anti-C7, it
was estimated that his serum C6 and C7 levels varied between 5
and 7 SD below the mean. The serum levels of C3 as well as
those of other components (Table 1) have been, for long
periods, in the normal range. The pedigree of his family is
shown in Figure 6. Six family members distributed on both the
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Fig. 5. Complement component concentrations in relatives of the ten
patients with MPGN with complement component deficiencies, The
concentration of the deficient component in the relative is expressed in
SD below the mean. The shaded area indicates the lower half of the
normal range. Abbreviations: M, mother; F, father, B, brother; S,
sister, MGF, maternal grandfather; MGM, maternal grandmother; MA,
maternal aunt; PU, paternal uncle.
maternal and paternal sides were partially deficient in both C6
and C7 and a maternal aunt had a low level of C6 but a normal
level of C7. Phenotypically, all those who were deficient were
C6A except the maternal grandmother who was C6B. Thus, the
mother and maternal aunt of the propositus did not inherit the
C6 variant present in their partially deficient mother, informa-
tive for the presence of a null structural gene [29]. All were
phenotypically C7'.
The component deficiencies of patients 7 and 8 were associat-
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Fig. 6. Pedigrees of patients 4, 5, and 6.
Values under symbols are the serum
concentrations of C6 and C7, expressed as sn
from the mean. The electrophoretic variants of
C6 are also indicated. All patients and family
members had C7', the common
electrophoretic variant of C7. NT equates not
tested.
ed with structural abnormalities of the component proteins.
Patient 7 had consistently low levels of C3 over the 15 years he
was followed (Fig. 3) as did four members of his family (Fig. 5).
Family members have also had low levels of factor B (Fig. 5),
but factor B levels in the propositus have been consistently at
the lower limit of the normal range (Table 1) and only occasion-
ally more than 2 SD below the mean. The propositus has also
consistently had low levels of CS but in other affected family
members, CS levels have been in the normal range. Study of
this family [31, 32] has shown that in the propositus and other
affected family members, the amplification C3 convertase,
C3b,Bb, is resistant to inactivation by factor H. It is postulated
that the defect is the result of a gene producing an abnormal C3
which, as C3b, either lacks a binding site for factor H or has an
abnormally low affinity for factor H. Thus, a portion of the
C3b,Bb formed spontaneously in vivo has a relatively long half-
life with the result that C3 levels are about one-half normal and
factor B levels tend to be low.
Patient 8 (Fig. 3) and four family members on the maternal
side (Figs. 5 and 7) have low levels of C7. Concentrations of C3
and other components have been in the normal range (Fig. 3 and
Table 1). Isoelectric focusing of the C7 of patient 8 has shown
that he has the common C71 protein 130] and also a variant of C7
not previously described consisting of duplication of the two
most cathodal C7 bands (Fig. 8). Isoelectric focusing in this
—7.2A —3.4A
—5.1
Patient 6
Partial C6 and
C7 deficiency
• Subtotal C6 and
C? deficiency
laboratory of sera from 765 individuals has shown, as observed
by Hobart, Joysey, and Lachmann [301, that approximately 1%
have distinctive variants of C7 but none of the variants have
conformed to that seen in patient 8. This variant is also present
in four family members who have low C7 concentrations (Fig.
7) as well as in the mother and a maternal great-uncle who have
C7 concentrations in the normal range.
Patient 9 has persistently had low levels of C6 and patient 10,
low levels of C8 but neither a null gene nor a structurally
abnormal component was demonstrable in either patient. Ex-
cept for a period during and after her pregnancy, patient 9 has
had levels of C6 more than 2 SD below the mean with normal
levels of C3 and of other components (Fig. 3 and Table 1). Her
mother and three brothers also have low levels (Figs. 5 and 7).
A null gene could not be demonstrated, however, in that the C6
of the patient, as well as of the deficient family members, was
phenotypically AB.
Patient 10 has had presistently low levels of C3, often with C3
nephritic factor demonstrable, over a period of 5 years (Fig. 4).
During this time, serum levels of other components, including
CS, C6 and C7, have been well within the normal range (Figs. 5
and Table 1), but C8 levels have been depressed, at times more
than 4 SD below the mean. Her mother, a sister and a brother
also have low concentrations of C8 (Figs. 5 and 7). By isoelec-
tric focusing in acrylamide, however, the alpha-gamma chain of
C6
C6 —2.2A
C7 +0.9
Patient 5
C6
C7
Partial C6
!11 1I deficiency
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Fig. 7. Pedigrees of patients 8, 9, and 10 with
partial C7, C6, and C8 deficiencies, respectively.
Values beneath the symbols indicate serum
concentrations of C6, C7, or C8, as designated,
expressed as SD from the mean. For C6 and C8 the
electrophoretic variants, designated A, B, or AB
are given. In the case of patient 8, the designation
R is used to indicate the family members who were
phenotypically C7' (see Figure 8 and Results).
All others were phenotypically C7'.
the C8 of the mother is AB. Isoelectric focusing in agarose
under conditions in which C8 is not dissociated also gives an
AB pattern (Fig. 7). Thus, the deficiencies in patients 9 and 10
cannot be attributed to null genes and there is no evidence of
structurally abnormal proteins. It is possible that the low
component levels in patients 9 and 10 and their families is the
result of a defect in a regulatory gene.
Complement component deficiencies in normal subjects and
patients with glomerulonephritides other than MPGN land Ill.
To assess the significance of the high frequency of component
deficiency in the patients with MPGN I and III, complement
profiles were performed on 163 normal subjects and 134 pa-
tients with other nephritides. Of the 163 normal subjects, 11
were found to have low levels of C2, C6, C7, or C8. The
concentrations in these subjects are shown graphically in Figure
9. C2 deficiency was present in three (1.8%). All three are
probably heterozygous deficient; low levels of C2 were found in
the mothers of two of these subjects and relatives of the third,
whose C2 level was more than 3 SD below the mean, were not
available. One subject was possibly heterozygous deficient in
C6 and had C6B. Another had a low level of this protein but was
phenotypically C6AB. Five subjects had levels of C7 more than
2SD below the mean. Family studies on these subjects indicated
low levels in the fathers of three but normal levels in the parents
of the other two. All the C7 deficient subjects had the common
C7' form of C7. The eleventh patient had a level of C8 2.1 SD
below the mean and two of her siblings were in the same range.
The levels in her parents were in the normal range. All with low
levels were C8AB and thus did not have a null gene. Thus,
component deficiencies similar to those in the MPGN patients
were present in 6.7% (11 of 163) of the normal subjects.
To provide more background for assessing the data from the
patients with MPGN I and III, patients with other glomerulone-
phritides were screened for complement component deficiency
using the same criteria as for the other groups. As shown in
Figure 10, four of 62 with AGN and three of 32 with SLE had
component deficiencies. The deficiencies could not be attribut-
ed to their acquired hypocomplementemia (see Methods). Fam-
ily members of one of the C2 deficient patients with SLE were
also deficient in this protein. Family studies could not be
performed on the others. None of 14 with MPGN type II and
none of 26 with Henoch-Schönlein nepthritis had deficiencies.
Thus, the prevalence of deficiencies in the patients with other
nephritides was 5.2% (7 of 134), about the same as in the normal
subjects.
Statistical significance of the differences in prevalence of
complement deficiencies. The data for frequency of component
deficiencies in all groups are summarized in Table 2. It is
apparent that the prevalence of component deficiencies in the
patients with MPGN I and III was greater than in any other
group and that the differences were highly significant. The
probability that the difference arose by chance is, in all compar-
isons, less than 0.002 and if the frequency in MPGN I and III is
compared with that in all 297 controls, the probability of the
difference arising by chance is 0.0002.
Discussion
The present observations indicate that low levels of one or
more complement components are significantly more prevalent
in patients with MPGN I and III than in normal subjects or in
patients with other glomerulonephritides. In those with MPGN,
the complement deficiency was persistent, involved several
different complement components, and there was evidence in
all cases that it was inherited. Thus, the deficiency was proba-
bly present since infancy. At least three types of inherited
defects caused the low levels. Six patients probably had one or
C7
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Fig. 8. Variant of C? found inpatient 8 and his family. A photograph of
the pattern produced by immunofixation is shown below and it is
schematically drawn above. The common C7 pattern (C7') is typified by
that of the maternal aunt and father. It consists, as appreciated in the
photograph, of three major bands. Not always visible is a fourth more
cathodal band; it was not distinguishable in the pattern made by the
father's serum. The variant, designated C7', is present in the proposi-
tus, his mother, and maternal grandmother. The basic pattern C7' is
seen in the specimens from these subjects; the C7' pattern of the
maternal grandmother is like that of the father in that the most cathodal
minor band is not visible. The variant, C7, is characterized by a
duplication of the most cathodal of the major bands and of the minor
band. Thus, these subjects are considered phenotypically to be C71,.
more null genes to account for their deficiency, two inherited
structurally abnormal components and in two, the reason for
the low levels in the propositi and their families could not be
determined. The low component levels could not be ascribed to
hypocomplementemia acquired through complement activation
since, with few exceptions, the survey used only specimens
obtained at times when the C3 concentration was in the normal
range and hence complement activation was absent or minimal.
Hypoproteinemia accompanying the glomerulonephritis was
also not a cause of the low levels. Patient 1 had a nephrotic
syndrome when first seen but his C2 concentration has subse-
quently remained low despite normalization of his serum pro-
tein levels. A nephrotic syndrome was not present in the others.
An age difference in serum levels between patients and controls
C2
-
C6C7 I
AB
Fig. 9. Serum concentrations of deficient complement components in
the 11 normal subjects with deficiencies. Values are expressed as SD.
The plot is similar to that of Figure 5.
C2 C6 C7 C8
I:I
H F
Fig. 10. Serum concentrations of deficient complement components in
patients with glomerulonephritides other than MPGN I and III. The
plot is similar to that of Figures 5 and 8. Squares indicate patients with
AGN and triangles, those with SLE.
also cannot be the explanation. Data for C7 and C8 levels in
infants and children are not available but serum concentrations
of C2 and C6 come into the adult range at age 6 months [33}.
The youngest patient in the present series was 5 years old.
Further, the patients with AGN were, on the average, younger
than those with MPGN but had far fewer component
deficiencies.
In the patients with MPGN, the persistence of the component
deficiency was much better documented than in the control
subjects in that measurements were made on serial serum
specimens obtained over long periods. For the controls, it was
assumed that if a component was on one occasion found to be
low, the deficiency was persistent. Likewise, family studies
could not be done on all control subjects with deficiencies and
in two with C7 deficiency, a similar deficiency in the parents
could not be documented. It should also be noted that in 5 of the
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Table 2. Prevalence of complement component deficiencies in normal subjects and patients with various glomerulonephntides
Percent
Categories
N of
subjects
N with
component
deficiencies
with
component
deficiencies
Significance
x2 P
MPGNI 24 6 25
MPGN III 20 4 20
Total MPGN I and III 44 10 22.7
Normal subjects 163 11 6.7 11.7 < 0.00I
Other glomerulonephritides
MPGNII 14 0 0
AGN 62 4 6.4
SLE 32 3 9.4
Henoch-Schflnlein 26 0 0
Total other nephritides 134 7 5.2 9.7 < 0.002
Total normal subjects and
other nephritides 297 18 6.0 14.1 0.0002
Abbreviations: AGN, acute postinfectious glomerulonephritis; MPGN, membranoproliferative glomerulonephritis; N, number; SLE, systemic
lupus erythematosus.
The value is significant as compared to the prevalence in patients with combined MPGN I and III.
18 control subjects (normals plus other nephritides) with defi-
ciency, the serum level of the deficient component was not
greatly depressed, ranging between 2.0 and 2.2 SD below the
mean. A true deficiency, therefore, may not have been present.
The levels of the deficient components in the MPGN patients
were, in the overall, considerably further from the normal
range. To the extent that the low levels in the controls were not
in fact persistent and did not represent true deficiencies, the
difference in prevalence would have correspondingly greater
significance.
The best explanation for the high frequency of inherited
component deficiency in the MPGN patients is that such a
deficiency is a predisposing factor in the pathogenesis of the
disease. How it predisposes is, however, not clear. It is obvious
that with six components or combinations of components
deficient (C2, C3-factor B, C6, C6-C7, C7, and C8), indicating
abnormality in a number of genetic loci, linkage of a null gene or
one producing an abnormal protein to one predisposing to the
disease is not a viable explanation. In all cases, small amounts
of the deficient component were present so that no pathway
was completely blocked. Thus, with the exception of patient 6
who had extremely low concentrations of C6 and C7, the
hemolytic function of the deficient component would be about
half normal. For example, Glass et al [15] found that in subjects
with probable heterozygous C2 deficiency, the C2 protein
concentration and C2 hemolytic function were approximately
half the normal mean. The CH50 titers of persons heterozygous
deficient in C2 average 75% of the normal mean; in 50%, the
CH50 titers fall within the normal range [15]. Heterozygous
deficiency of C6 and C7 have virtually no effect on CH50 titers
[34]. In addition, these deficiencies would not affect the com-
plex releasing activity of the plasma in vitro [35, 36], predispose
to infection or in other ways markedly affect the immune
system. Yet from the present data, it would appear that
longstanding partial deficiency of a component can, in some
subjects, be a factor predisposing to MPGN.
A comparison of the clinical and laboratory observations on
the MPGN I and III patients with and without inherited
component deficiency revealed no differences in severity of
disease, age at diagnosis or in degree of acquired hypocomple-
mentemia. In the ten patients with inherited component defi-
ciencies, mesangial proliferation had the typical diffuse pattern
in eight. In one (patient 4) the proliferation was focal and
segmental [37] and patient 5 had chronic lobular disease [38].
As noted in the introduction to our study, a number of
patients with MPGN have been reported with complete or
nearly complete C2 deficiency. In addition, three patients with
recurrent anaphylactoid purpura have been homozygous defi-
cient in this component [39—41]. Heterozygous C2 deficiency
has also been noted by others to be associated with SLE.
Agnello [6] found 5% of 204 individuals with heterozygous C2
deficiency to have SLE. Glass et al [15] measured serum C2
concentrations in 130 patients with SLE and found three who
were definitely heterozygous deficient, one probably heterozy-
gous deficient, and three possibly heterozygous deficient. As-
suming an inherited C2 deficiency existed in all, the prevalence
(5.1%) was significantly greater than the prevalence of possible
heterozygous deficiency in normal subjects (1.2%) (P = 0.004).
In agreement with these observations, of the 32 patients with
SLE in the present study, 6.2% had C2 deficiency. The associa-
tion of heterozygous C2 deficiency with SLE has been various-
ly ascribed to linkage of the null gene for C2 with an immune
response gene predisposing to SLE or to the potential for a
compromised classical pathway produced by the low C2 and
somewhat depressed factor B levels [15].
In contrast to partial deficiency of C2, there have been no
reports of disease associated with partial deficiencies of C6, C7,
and C8. Homozygous deficiencies of these components have
usually been associated with Neisseria infection [34] and occa-
sionally with SLE, as summarized by Zeitz et a! [9].
However, immune complex disease in association with C3
deficiency has been reported by a number of authors. In a
Membranopro1ferative glomerulonephritis 689
family described by Pussell Ct a! [16], a woman of 20 years with
heterozygous C3 deficiency showed, by renal biopsy, features
of MPGN. Two of her siblings, both homozygous deficient in
C3, had low grade proteinuria, one with, in addition, micro-
scopic hematuria, but their renal status was not further investi-
gated. A third sibling, also homozygous deficient in C3, had
hematuria, proteinuria, and renal artery stenosis. McLean et a!
[17] reported a 14-year-old girl with chronic glomerulonephritis
of immune complex origin who had a serum C3 concentration
which, on two of five occasions, was more than 2 SD below the
mean, presumably because she had a hypomorphic variant of
C3 (C3f). A brother with C3fS but normal serum C3 levels had
proteinuria and hematuria but was not further studied. Two
other family members with C3fS and persistently low serum C3
concentrations had no evidence of nephritis. Wyatt et al [18]
reported two families in which several members had low serum
levels of C3 and factor B associated with a partial deficiency of
factor H. Of members so affected, one had the hypocomple-
mentemic vasculitis syndrome and two had IgA nephropathy. A
fourth had hematuria and proteinuria but a definite diagnosis
was not made. The present systematic study greatly strengthens
the circumstantial evidence provided by these anecdotal obser-
vations that deficiencies involving a number of components can
be associated with immune complex disease. The wide variety
of components involved, however, makes it difficult to concep-
tualize the mechanism by which deficiencies predispose. A
number of as yet unidentified factors may be involved.
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